Trial Profile
Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 May 2016 New trial record